IR Biosciences Holdings, Inc. Share Price
Equities
IRBS
US46264M3034
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -100.00% | -100.00% |
Sales 2009 | - | Sales 2010 | - | Capitalization | 11.96L 9.97Cr |
---|---|---|---|---|---|
Net income 2009 | -60L -50Cr | Net income 2010 | -50L -42Cr | EV / Sales 2009 | - |
Net Debt 2009 | 58.1L 48Cr | Net Debt 2010 | 36.69L 31Cr | EV / Sales 2010 | - |
P/E ratio 2009 |
-0.37
x | P/E ratio 2010 |
-0.2
x | Employees | 4 |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01/03/01 | |
John N. Fermanis
DFI | Director of Finance/CFO | 70 | 01/04/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01/03/01 |
1st Jan change | Capi. | |
---|---|---|
-100.00% | 17 | |
+29.77% | 4.92TCr | |
+1.00% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.68% | 2.61TCr | |
-22.99% | 1.87TCr | |
+8.22% | 1.33TCr | |
+32.41% | 1.23TCr | |
-1.62% | 1.2TCr |
- Stock Market
- Equities
- IRBS Stock